MTOR and cancer: Importantly, the underlying molecular mechanism of ITZ’s anti-cancer effect has been reported via inhibiting hedgehog signaling, Wnt pathway and/or reducing mTOR expression, recognized as an mTOR inhibitor (Head et al., 2015; Wang et al., 2020).